Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic ...

The number of new drugs approved each year increased steadily in the first few years of the analysis period, and more than 40 ...

The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

LEO Pharma A/S, a global leader in medical dermatology, has today announced its submission of a New Drug Application (NDA) to the National Medical Products Administration (NMPA) for Enstilar ...

Zydus Lifesciences has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture ...

HART Hub funding – to establish a Homelessness and Addiction Recovery Treatment hub in Sault Ste. Marie — is vital to help ...